共 74 条
- [1] Patterson SM(2012)Interventions to improve the appropriate use of polypharmacy for older people Cochrane Database Syst Rev 5 CD008165-995
- [2] Hughes C(2012)Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes J Clin Epidemiol 65 989-1523
- [3] Kerse N(2006)Polypharmacy and prescribing quality in older people J Am Geriatr Soc 54 1516-450
- [4] Cardwell CR(1996)Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population Am J Emerg Med 14 447-918
- [5] Bradley MC(2007)The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register Drug Saf 30 911-393
- [6] Gnjidic D(2010)Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts Diabetes Res Clin Pract 87 385-1959
- [7] Hilmer SN(2004)Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 164 1957-316
- [8] Blyth FM(2007)Polypharmacy and the balance of medication benefits and risks Am J Geriatr Pharmacother 5 314-172
- [9] Naganathan V(2012)Factors leading to excessive polypharmacy Clin Geriatr Med 28 159-351
- [10] Waite L(2007)Polypharmacy in elderly patients Am J Geriatr Pharmacother 5 345-132